Bacthera and Seres Therapeutics plan to commercialize first live biotherapeutic product

A new manufacturing facility will become operational at Lonza’s Visp site in 2024

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

Lonza and Bioqube Ventures, a European venture capital firm with a dual investment model including venture creation, have partnered to develop and manufacture biologics... Read More

FormattedPicture

FOOD INGREDIENTS NEWS

A panel of industry experts selected Chr. Hansen’s FreshQ concept at this year’s Fi Europe Innovation Awards in Frankfurt, Germany. The Food Tech Innovation... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Health claims play a crucial role in communicating with consumers but different regional approaches reveal a fractured scene. Experts from Gencor, Lonza,... Read More

FormattedPicture

BUSINESS NEWS

This week in nutrition news, Nuun, a brand of Nestlé Health Science, earned B Corporation (B Corp) certification due to its public transparency and verified... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Nestlé Health Science (NHSc) is exploring the effectiveness of its ketogenic nutritional supplements on reducing migraines. “The advantage of a... Read More

trans